SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-04-003875
Filing Date
2004-08-09
Accepted
2004-08-09 13:30:02
Documents
5
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q DATED 6/30/04 b51124tte10vq.htm 10-Q 342961
2 EX-31.1 SECTIO0N 302 CERTIFICATION OF CEO b51124ttexv31w1.htm EX-31.1 7363
3 EX-31.2 SECTION 302 CERTIFICATION OF CFO b51124ttexv31w2.htm EX-31.2 7376
4 EX-32.1 SECTION 906 CERTIFICATION OF CEO b51124ttexv32w1.htm EX-32.1 7363
5 EX-32.2 SECTION 906 CERTIFICATION OF CFO b51124ttexv32w2.htm EX-32.2 2821
  Complete submission text file 0000950135-04-003875.txt   369876
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21481 | Film No.: 04960458
SIC: 2836 Biological Products, (No Diagnostic Substances)